10 ML foscarbidopa 12 MG/ML / foslevodopa 240 MG/ML Injection [Vyalev] — RxCUI 2695789
RxNorm drug concept · Semantic branded drug
RxCUI 2695789
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2695789
Official name10 ML foscarbidopa 12 MG/ML / foslevodopa 240 MG/ML Injection [Vyalev]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asVyalev (foscarbidopa 120 MG / foslevodopa 2400 MG per 10 ML) Injection; VYALEV 120 MG / 2400 MG in 10 ML Injection
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)67 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Levodopa and Carbidopa: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Levodopa is the medicine that actually works in your brain — it crosses into the brain and gets converted into dopamine, the chemical that Parkinson's disease depletes. The problem...
- What exactly does levodopa and carbidopa do, and why do I need both?
- Generally yes, but the timing and content of your meals can matter. High-protein foods — like large servings of meat, eggs, or dairy — can compete with levodopa for absorption in y...
- Can I eat normally while taking this medication?
🕸️ Concept Web — How 10 ML foscarbidopa 12 MG/ML / foslevodopa 240 MG... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
10 ML foscarbidopa 12 MG/ML / foslevodopa 240 MG/ML Injection [Vyalev]
RxCUI 2695789 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 5
The active substance itself — no strength, form, or brand attached yet.
-
Carbidopa
2019IN -
Levodopa
6375IN -
Carbidopa / levodopa
103990MIN -
Foscarbidopa
2695774PIN -
Foslevodopa
2695775PIN
-
Carbidopa
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Vyalev
2695784BN
-
Vyalev
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Carbidopa / levodopa Injection
2695779SCDF -
Foscarbidopa / foslevodopa Injection
2695781SCDFP -
Carbidopa / levodopa Injectable Product
2695778SCDG -
Foscarbidopa / foslevodopa Injectable Product
2695780SCDGP -
Carbidopa / levodopa Injection [Vyalev]
2695787SBDF -
Foscarbidopa / foslevodopa Injection [Vyalev]
2695788SBDFP -
Vyalev Injectable Product
2695786SBDG -
Injection
1649574DF - +1 more in this family
-
Carbidopa / levodopa Injection
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
10 ML foscarbidopa 12 MG/ML / foslevodopa 240 MG/ML Injection
2695782SCD -
Foscarbidopa 12 MG/ML
2695776SCDC -
Foslevodopa 240 MG/ML
2695777SCDC -
Foscarbidopa 12 MG/ML / foslevodopa 240 MG/ML [Vyalev]
2695785SBDC
-
10 ML foscarbidopa 12 MG/ML / foslevodopa 240 MG/ML Injection
Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
10 ML foscarbidopa 12 MG/ML / foslevodopa 240 MG/ML Injection
SCD · 2695782 -
Foscarbidopa 12 MG/ML
SCDC · 2695776 -
Foslevodopa 240 MG/ML
SCDC · 2695777 -
Carbidopa / levodopa Injection
SCDF · 2695779 -
Foscarbidopa / foslevodopa Injection
SCDFP · 2695781 -
Carbidopa / levodopa Injectable Product
SCDG · 2695778 -
Foscarbidopa / foslevodopa Injectable Product
SCDGP · 2695780
Brand-Name Concepts
-
Foscarbidopa 12 MG/ML / foslevodopa 240 MG/ML [Vyalev]
SBDC · 2695785 -
Carbidopa / levodopa Injection [Vyalev]
SBDF · 2695787 -
Foscarbidopa / foslevodopa Injection [Vyalev]
SBDFP · 2695788 -
Vyalev Injectable Product
SBDG · 2695786 -
Vyalev
BN · 2695784
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2695789 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00074-0501-01 | 7 VIAL, SINGLE-DOSE in 1 CARTON (0074-0501-01) / 10 mL in 1... | Vyalev | AbbVie Inc. | 2022-04-12 |
Observed labelers:
AbbVie Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J7356 | Inj foscarb/foslevodopa 5 mg | 1 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.